Drugs / rEPO
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00663416 | Mar → Oct 2008 | stroke disorder | Stem Cell Therapeutics Corp. | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | rEPO | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00663416 ↗ |
| Route | Intravenous | “rEPO 30,000 IU, IV” NCT00663416 ↗ |